India's drugmakers ramped up C-suite hiring in 2024 to support expansion plans amid favourable global business tailwinds, multiple industry executives said.
Search firms and companies confirmed increased hiring of chief technology officers (CTOs), chief financial officers (CFOs), chief human resources officers (CHROs), regulatory officers, as well as business leaders for emerging and regulated markets.
"Indian firms are creating more entrepreneurial, scale-driven opportunities. For a candidate willing to take a three-to five-year horizon, this becomes attractive given skin-in-the-game rewards like restricted stock units and Esops," Sachin Rajan, managing director at executive search and leadership advisory firm Russell Reynolds Associates said.
Large Indian companies want to differentiate themselves and pivot towards specialized portfolios, as well as focus on enterprise buyers such as hospital chains, and governments, Rajan said.
"This requires leadership both in commercial business units, sales and marketing functions, but also leaders who can enable pivots in functions like regulatory and medical," he said.
Denne historien er fra January 02, 2025-utgaven av Mint Hyderabad.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent ? Logg på
Denne historien er fra January 02, 2025-utgaven av Mint Hyderabad.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent? Logg på
NRIs: TDS compliance for share buybacks
As a resident Indian promoter of a private limited company, I'm buying back shares from a non-resident individual who helped secure export orders. Does this payment fall under the LRS, and what TCS/TDS applies?
LTIMindtree's global markets head quits
TIMindtree Ltd's president of global markets, Sudhir Chaturvedi, has quit the company, leaving chief operating officer Nachiket Deshpande as the frontrunner to succeed current chief executive Debashis Chatterjee, whose term ends later this year.
High on hype: Is it still the rise of CBD products in India?
CBD products may be everywhere in India, but premium pricing and stigma continue to impact their acceptance
AI agent-based platforms are next big thing for biz: Google
Google's agentic models can execute tasks autonomously under human supervision
Macrotech moves HC to stop Abhinandan Lodha's firm using name
The House of Abhinandan Lodha was established in 2021 when Macrotech Developers went public
Does India's Fiscal Profile Need a Facelift?
The role of fiscal policy becomes more crucial in the current cyclical slowdown
India's credit guarantee scheme for startups holds high potential
It provides much needed collateral-free loans at a time when risk capital has been slowing down
Sebi Proposes Stricter Disclosure Norms for Non-Profit Entities
The Securities and Exchange Board of India (Sebi) on Monday floated a consultation paper proposing revisions to the Social Stock Exchange (SSE) framework.
Budget: Can India Switch to a Single Income Tax Rate?
The tax slab rate system has been a cornerstone of India's tax framework since inception.
Founders Step Back From PharmEasy, Eye Consumer Space
Siddharth Shah, the last of the co-founders, will continue to be the MD and CEO of the company
